a company which engages in discovery, development and commercialization of novel anti infectives
Industry PharmaceuticalsOther
A.I.dvisor tells us that SCYX and ESPR have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and ESPR's prices will move in lockstep.
Ticker / NAME | Correlation To SCYX | 1D Price Change % | ||
---|---|---|---|---|
SCYX | 100% | -3.73% | ||
ESPR - SCYX | 26% Poorly correlated | -8.23% | ||
ORGO - SCYX | 26% Poorly correlated | +28.41% | ||
AMPH - SCYX | 24% Poorly correlated | -4.67% | ||
CURLF - SCYX | 23% Poorly correlated | +9.80% | ||
HNSPF - SCYX | 22% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To SCYX | 1D Price Change % |
---|---|---|
SCYX | 100% | -3.73% |
antibiotics theme (3 stocks) | 25% Poorly correlated | -2.82% |
pharmaceuticals theme (159 stocks) | 25% Poorly correlated | -1.94% |
Pharmaceuticals: Other theme (235 stocks) | 18% Poorly correlated | -0.48% |
Pharmaceuticals theme (308 stocks) | 11% Poorly correlated | -0.54% |